Navigation Links
MAQUET Cardiovascular Announces Leading Robotic Heart Surgeon Performs First Beating Heart Fully Endoscopic Bypass Surgery Using Miniaturized Cardiopulmonary Bypass System
Date:9/24/2009

tially be improved if the heart is not stopped (Puskas et al, Ann Thorac Surg, 2007;84:1447-56).

The revolutionary MECC system, in contrast, typically requires the placement of two catheters in the patient's upper thigh and does not require the surgeon to stop the patient's heart during surgery. The combined effect of allowing the heart to remain beating, the reduction of tubing needed, and the reduced amount of fluid required to dilute the blood versus that needed in traditional bypass, offers improved safety and the ability to offer a minimally invasive approach to the patient. Diluting the patient's blood during routine bypass surgery has been associated with an increased need for blood transfusions. MECC technology requires only a small amount of fluid to be given to the patient and, therefore, decreases the likelihood of a necessary blood transfusion.

"The MECC system's ability to improve patent safety and outcomes is the gold standard quality we look to incorporate into our cardiopulmonary perfusion products," said Raoul Quintero, President and CEO, MAQUET Cardiovascular US Sales LLC. "Physicians have been asking for new technology that offers alternatives for both conventional and high-risk patients. Our MECC technology provides a revolutionary new platform for physicians who want to perform minimally-invasive beating heart surgery and is an alternative to traditional perfusion technology."

The MECC system has incorporated many built-in features over existing technologies that may benefit patients:

  • MECC systems have heparin coating called BIOLINE, providing excellent biocompatibility and improving overall safety
  • Reduction in blood transfusions
  • Minimized systemic inflammatory response through MECC's reduced surface activation
  • Prime volume is significantly lowered from the small size of MECC's tubes and catheters resulting in a decr
    '/>"/>

SOURCE MAQUET Cardiovascular
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Terumo Cardiovascular Systems Files Patent Infringement Complaint Against Maquet Affiliates
2. Leading Cardiovascular Surgeons Gather from Around the World to Share Ross Procedure Survival Data, Techniques at 2nd Annual Summit
3. Volcano Corporation Announces Schedule of Events for the 2009 Transcatheter Cardiovascular Therapeutics (TCT) Conference
4. CryoLifes Second Annual Surgical Congress for the Ross Procedure to Draw More than 130 Cardiovascular Surgeons from Around the World
5. Bioheart Strengthens Executive Team in Order to Accelerate Business Plan and Enhance Its Position in the Cardiovascular Stem Cell Therapy Industry
6. VIA Pharmaceuticals Announces Complete Enrollment in FDG-PET Phase 2 Study of VIA-2291 in Cardiovascular Patients
7. Athera Signs Agreements With German and UK Distributors for New Cardiovascular Biomarker
8. Exenatide Clinical Data Analysis Shows No Increased Risk of Cardiovascular Events
9. Cordex Pharma Presents New Frontiers in Cardiovascular Medicines on January 29
10. Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by Genomas Clinical Study
11. Richter-Helm and Athera Biotechnologies Partner in Development of Recombinant Protein to Treat Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... (PRWEB) December 23, 2014 Earlier this ... James L. Sherley, director of the Adult Stem Cell ... an often overlooked and under appreciated unique property of ... by Distributed Stem Cells: Misunderstood in the Past, Important ... to congress participants. He gave the address at ...
(Date:12/24/2014)... Island, New York (PRWEB) December 23, 2014 ... and the Long Island Affiliate of ITRA Global, the national ... slow but steady recovery. This is evidenced by the ... the strong stock market. Low energy costs have held ... The only negative is the housing market remaining soft. ...
(Date:12/24/2014)... report expects global cell isolation and expansion market to ... carefully analyzed data about the vital drivers, restraints, trends, ... Copy of Report @ http://bit.ly/1yUxy0T , According ... will keep witnessing growth at an impressive CAGR during ... by rapid technological advancements, government funding and investments, and ...
(Date:12/24/2014)... Texas , Dec. 23, 2014 ... company focused on gynecologic disease, announced today that ... Schuler , Birchview Fund LLC and several Vermillion ... of unregistered shares of Vermillion,s common stock and ... stock in a private placement.  ...
Breaking Biology Technology:Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 2Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 3Adult Stem Cell Technology Center, LLC’s Director Sherley's Address on What’s Holding Back Regenerative Medicine Featured on Omics Group Website 4ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 2The Cell Expansion Market is Expected to Reach $14.8 billion by 2019 - New Research Report by MarketsandMarkets 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5
... Jan. 11, 2011 Reportlinker.com announces that ... in its catalogue: Sample ... (Results of The Kalorama Survey of Labs) ... Sample preparation and library preparation are ...
... of Chemistry Dunwei Wang has received a career award ... energy technology research and expand the community outreach programs ... on developing novel technologies for clean energy applications, has ... a flexible webbing of nano-scale wires that has shown ...
... N.C., Jan. 10, 2011 Takeda Pharmaceutical Company ... they have entered into an exclusive, worldwide licensing ... for the risk of Alzheimer,s disease in high-risk ... study pioglitazone in connection with the TOMM40 biomarker ...
Cached Biology Technology:Reportlinker Adds Sample Preparation and Library Preparation for DNA Sequencers (Results of The Kalorama Survey of Labs) 2Reportlinker Adds Sample Preparation and Library Preparation for DNA Sequencers (Results of The Kalorama Survey of Labs) 3Developer of 'nanonets' snares National Science Foundation Career Award 2Takeda and Zinfandel Pharmaceuticals Sign Licensing Agreement for Alzheimer's Disease Biomarker in Combination with Pioglitazone 2
(Date:12/3/2014)... 2014   Marvin Test Solutions , a ... for military, aerospace, and manufacturing organizations, today announced ... TS-900 PXI semiconductor test platform . The ... systems to customers at a fraction of the ... ATE. "Our semiconductor customers asked ...
(Date:11/21/2014)... , Nov. 19, 2014  Earlier this year ... York College, and one of the most prolific inventors ... that are transmitted from Smartphones to third party agencies. ... and has one of the earliest known patents in ... usage in the military, child care, elder care and ...
(Date:11/21/2014)... JOSE, Calif. , Nov. 20, 2014   ... global leader in microcontroller (MCU) and touch technology solutions, ... digital temperature sensors with the widest V cc ... delivers higher temperature accuracy and faster I 2 C ... registers and serial EEPROM memory making them ideal for ...
Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 2Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 3Patented Biosensor Wearable Technology Provides a More Civilized Method of Quarantine 4Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 2Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 3Atmel Launches Industry's First Wide-V(cc) Low-Power Temperature Sensor Family 4
... a majority of hip fracture patients of all ages and ... a new study presented today at the 2013 Annual Meeting ... whether or not living in a warm, sunny climate improves ... vitamin D levels of 1,539 patients, including 448 acute hip ...
... environmental engineer has received a three-year, $561,730 grant to identify ... water providers can take action to contain and curb the ... Foundation have awarded Assistant Professor Hyeok Choi the grant to ... exist so that the harmful algae can be monitored. , ...
... Some diseases are caused by single gene mutations. Current ... produce hundreds of potential gene candidates, making it difficult ... a team of researchers led by Rockefeller University scientists ... the hunt for disease-causing genes. The investigation, spearheaded ...
Cached Biology News:UT Arlington engineer to search for bad algal blooms 2Researchers create map of 'shortcuts' between all human genes 2Researchers create map of 'shortcuts' between all human genes 3
E1A (adenovirus early region 1)...
... 1 ( Abpromise for all tested ... peptide: MAATGANAEK AESHNDCPVR LLNPNIAKMK EDILYHFNLT TSRHNFPALF GDVKFVCVGG ... acids 1-99 of Human Uridine Phosphorylase 1 ... 7378 Swiss Protein ID: ...
Nucleobindin 1 [NUCB1]...
Presenilin-1, N-terminus....
Biology Products: